Navigation Links
Amarin to Present at the 10th Annual Needham Healthcare Conference
Date:3/31/2011

MYSTIC, Conn. and DUBLIN, March 31, 2011 /PRNewswire/ -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Executive Chairman and Chief Executive Officer, Joseph Zakrzewski, will present at 8:40 a.m. EDT on April, 6, 2011 at the 10th Annual Needham Healthcare Conference in New York City. Additionally, Amarin's President, John Thero, will be available at the conference to respond to questions from investors. A live Webcast of the presentation will be available at the following URL:

http://wsw.com/webcast/needham44/amrn/

About Amarin

Amarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's lead product candidate is AMR101, the active ingredient in which is ethyl-EPA (ethyl icosapentate). On November 29, 2010, the Company reported positive, statistically significant top-line results from the MARINE trial, the first of its Phase 3 clinical trials of AMR101. In the MARINE trial, AMR101 was investigated as a treatment for very high triglycerides (>500 mg/dL). AMR101 is presently being investigated in a second Phase 3 clinical trial, the ANCHOR trial, for the treatment of patients on statin therapy with high triglycerides (e200 and <500mg/dL) with mixed dyslipidemia. The MARINE trial was, and the ANCHOR trial currently is, conducted under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development.

Investor Contact Information:
Stephen D. Schultz
Investor Relations and Corporate Communications
Amarin Corporation
In U.S.: +1 (860) 572-4979 x292
<
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amarin Reports Year-End and Q4 2010 Results
2. Amarin to Present at Two Upcoming Investor Conferences
3. Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
4. Amarin Provides 2010 Year-End Review to Shareholders
5. Amarin Announces Successful Completion of Offering of American Depositary Shares
6. Amarin Announces Underwriters Exercise of Over-Allotment Option
7. Amarin Prices Public Offering of American Depositary Shares
8. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
9. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
10. Amarin to Present at UBS Life Sciences Conference
11. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... /CNW/ - The Canadian Pharmacists Association (CPhA) urges the federal ... that all Canadians have the opportunity to protect themselves ... immunization. The lack of access to HPV vaccination programs ... is needlessly putting the health of Canadians at risk. ... to pose a significant threat to the health of ...
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... England Journal of Medicine the B.E.S.T,study conducted in ... DISEASE CAN BE CONTROLLED,SUCCESSFULLY” , Prof. Fabbri: “Daily ... million 200 thousand people”.,Chiesi’s commitment to pneumological research ... to the daily dose,of cortisone necessary for the ...
... in AACR Cancer Journal , AUSTIN, Texas--(BUSINESS WIRE)--May ... of,data describing the dramatic clinical benefit of its ... inherited form of cancer known as,Li-Fraumeni Syndrome (LFS), ... p53 tumor suppressor gene. This is the,first reported ...
Cached Medicine Technology:Mild Asthma, a Revolutionary Therapy from Italian Research 2Mild Asthma, a Revolutionary Therapy from Italian Research 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
(Date:7/6/2015)... ... 06, 2015 , ... Acara Partners, a leading business team ... its complimentary educational webinar series for the summer of 2015. ... their clients through targeted marketing, sales, digital communications, branding and business development programs. ...
(Date:7/6/2015)... ... ... Olive Fertility Centre is proud to announce that Olive medical director Dr. Jason ... department of Family Practice. , “This award is a real honour,” says Dr Hitkari. ... changing so rapidly and we are also developing new models of patient-centred care that ...
(Date:7/6/2015)... Chester, NJ (PRWEB) , ... July 06, 2015 ... ... CancerHopeNetwork.org. The redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to ... who has survived the same cancer. , “Receiving a cancer diagnosis is often ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and ... The newly constructed urgent care center will serve residents and visitors in the Cutler ... being MD Now’s 22nd South Florida location, the new facility will be the fourth ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los Angeles ... achieve their ideal appearance through comprehensive treatment solutions. Individuals that want to make multiple ... and receive a plan that resolves each of their needs. , "Anytime I ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... more likely to misuse prescribed drugs, suffer flareups ... patients who use herbal remedies experience increased symptoms and ... Researchers followed 326 asthma patients for 33 months. Of ... and used prescribed inhaled corticosteroids (ICS) less often than ...
... , , Wounded Veterans Face Growing ... Feb. 5 Today, Iraq and Afghanistan ... organization representing veterans of the wars in Iraq and ... bureaucratic roadblocks, lengthy waits for care, and complicated disability systems facing ...
... articles, whose lead or senior authors are nationally known ... Association (AMIA), appear in the Feb. 2010 issue of ... the future of health care delivery in an increasingly ... These articles explain the critical role that information technology, ...
... ... ... ( www.aspendent.com ), one of the largest and fastest-growing providers of denture and dental care ... dental offices for an expansion of nearly 25 percent. The openings, which included the company’s ...
... sugar of children, teens stable longer , THURSDAY, Feb. 4 ... teenagers with type 1 diabetes could benefit by using an ... blood sugar levels during sleep and help them control their ... issue of The Lancet , examined use of an ...
... ... its LeGoo™ off-pump coronary artery bypass clinical study, based on a protocol reviewed by ... will be filed with the FDA as part of the company,s submission for U.S. ... ...
Cached Medicine News:Health News:Herbals Not the Answer for Asthma, Study Shows 2Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 2Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 3Health News:New IAVA Report Reveals Red Tape Facing Veterans in the Military and VA Health Care and Disability Systems 4Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 2Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 3Health News:Aspen Dental Opens 44 New Offices, Welcomes 340,000 New Patients in 2009 2Health News:Aspen Dental Opens 44 New Offices, Welcomes 340,000 New Patients in 2009 3Health News:Artificial Pancreas Helps Type 1 Diabetics During Sleep 2Health News:Pluromed Announces Completion of Enrollment in LeGoo&#8482; Cardiac Bypass Clinical Trial 2Health News:Pluromed Announces Completion of Enrollment in LeGoo&#8482; Cardiac Bypass Clinical Trial 3
... determination of Ang II is ... the pharmacological effect and efficiency ... angiotensin converting enzyme inhibitors (ACE ... antagonists as well as for ...
... antigen test is a visual ... presumptive qualitative detection of Respitory ... specimens in neonatal and pediatric ... test has a built-in procedural ...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
... BD Directigen EZ RSV Test utilizes a new, ... one device for rapid RSV detection. The testing ... method whereby dried reagents have already been applied ... a two-step process, with clear-cut results shown by ...
Medicine Products: